Associate Professor Lorenz H Lehmann

University Hospital Heidelberg, Heidelberg (Germany)

Membership: ESC Professional Member

Follow

Contributor content

Which is the best model to study cancer treatment-related cardiovascular toxicity?

Session

Which is the best model to study cancer treatment-related cardiovascular toxicity?

19 June 2026

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources